Latest Breaking News On - Transfusion dependent beta thalassemia - Page 5 : comparemela.com

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSaudi arabiaCity ofUnited kingdomKingdom of saudi arabiaGreat britainReshma kewalramaniExchange commissionHealthcare products regulatory agencyCompanies to workEuropean medicines agencyHealth canadaVertex pharmaceuticals incorporated nasdaqVertex pharmaceuticals incorporatedHealthcare conferenceChief executive officer

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

BOSTON, January 07, 2024 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 11:15 a.m. ET/8:15 a.m. PT.

Saudi arabiaUnited statesUnited kingdomCity ofKingdom of saudi arabiaGreat britainHeather nicholsReshma kewalramaniCompanies to workEuropean medicines agencyVertex pharmaceuticals incorporated nasdaqExchange commissionVertex pharmaceuticals incorporatedHealthcare products regulatory agencyHealth canadaHealthcare conference

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesSaudi arabiaKingdom of saudi arabiaGreat britainHeather nicholsReshma kewalramaniCompanies to workVertex pharmaceuticals incorporatedHealthcare products regulatory agencyHealth canadaEuropean medicines agencyExchange commissionVertex pharmaceuticals incorporated nasdaqPharmaceuticals incorporated

Vertex Pharmaceuticals Incorporated: Vertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Vertex Pharmaceuticals Incorporated: Vertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSaudi arabiaCity ofGreat britainManisha paiStefan klotterFranco locatelliHeather nicholsExchange commissionDepartment of pediatric hematologyVertex pharmaceuticals incorporatedEuropean commissionCompanies to workDrug authorityCommittee for medicinal products human use

Vertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

- If approved by the European Commission, patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thalassemia, for whom hematopoietic stem cell.

United statesCity ofUnited kingdomSaudi arabiaGreat britainFranco locatelliEuropean unionExchange commissionCatholic university of the sacred heartCompanies to workCommittee for medicinal products human useEuropean medicines agencyDrug authorityVertex pharmaceuticals incorporated nasdaqDepartment of pediatric hematologyDrug administration